Physician preference items: what factors matter to surgeons? Does the vendor matter?

被引:23
作者
Burns, Lawton R. [1 ]
Housman, Michael G. [2 ]
Booth, Robert E. [3 ]
Koenig, Aaron M. [4 ]
机构
[1] Univ Penn, Dept Hlth Care Management, Wharton Sch, 3641 Locust Walk, Philadelphia, PA 19104 USA
[2] Singularity Univ, Moffett Field, CA USA
[3] 3B Orthopaed, Langhorne, PA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Wang Ambulatory Care Ctr, Boston, MA USA
关键词
preference; surgeons; orthopedics; hip implants; PPIs;
D O I
10.2147/MDER.S151647
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: The USA devotes roughly $200 billion (6%) of annual national health expenditures to medical devices. A substantial proportion of this spending occurs during orthopedic (eg, hip and knee) arthroplasties - two high-volume hospital procedures. The implants used in these procedures are commonly known as physician preference items (PPIs), reflecting the physician's choice of implant and vendor used. The foundations for this preference are not entirely clear. This study examines what implant and vendor characteristics, as evaluated by orthopedic surgeons, are associated with their preference. It also examines other factors (eg, financial relationships and vendor tenure) that may contribute to implant preference. Methods: We surveyed all practicing orthopedic surgeons performing 12 or more implant procedures annually in the Commonwealth of Pennsylvania. The survey identified each surgeon's preferred hip/knee vendor as well as the factors that surgeons state they use in selecting that primary vendor. We compared the surgeons' evaluation of multiple characteristics of implants and vendors using analysis of variance techniques, controlling for surgeon characteristics, hospital characteristics, and surgeon-vendor ties that might influence these evaluations. Results: Physician's preference is heavily influenced by technology/implant factors and sales/service factors. Other considerations such as vendor reputation, financial relationships with the vendor, and implant cost seem less important. These findings hold regardless of implant type (hip vs knee) and specific vendor. Conclusion: Our results suggest that there is a great deal of consistency in the factors that surgeons state they use to evaluate PPIs such as hip and knee implants. The findings offer an empirically derived definition of PPIs that is consistent with the product and nonproduct strategies pursued by medical device companies. PPIs are products that surgeons rate favorably on the twin dimensions of technology and sales/service.
引用
收藏
页码:39 / 49
页数:11
相关论文
共 42 条
[1]  
[Anonymous], 2001, EC OUTLOOK
[2]   Total Joint Arthroplasty: Trends in Medicare Reimbursement and Implant Prices [J].
Belatti, Daniel A. ;
Pugely, Andrew J. ;
Phisitkul, Phinit ;
Amendola, Annunziato ;
Callaghan, John J. .
JOURNAL OF ARTHROPLASTY, 2014, 29 (08) :1539-1544
[3]  
Burns L.R., 2002, HLTH CARE VALUE CHAI
[4]   Surgeon evaluation of suture and endo-mechanical products [J].
Burns, Lawton R. ;
Lee, J. Andrew ;
Bradlow, Eric T. ;
Antonacci, Anthony .
JOURNAL OF SURGICAL RESEARCH, 2007, 141 (02) :220-233
[5]  
Burns LR, 2012, BUSINESS OF HEALTHCARE INNOVATION, 2ND EDITION, P515
[6]  
Cassak D, 2005, VIVO, V23, P27
[7]  
Cassak D, 2004, VIVO, V22, P25
[8]  
DeJohn P., 2005, HOSP MAT MANAG, V30, P9
[9]  
Donahoe G, 2012, ESTIMATES MED DEVICE
[10]  
ECRI Institute, 2009, PLYM M PA ECRI I